|1.||Redmann, Veronika: 1 article (01/2015)|
|2.||Gardner, Thomas J: 1 article (01/2015)|
|3.||Cohen, Tobias: 1 article (01/2015)|
|4.||Tortorella, Domenico: 1 article (01/2015)|
|5.||Lau, Zerlina: 1 article (01/2015)|
|6.||Felsenfeld, Dan: 1 article (01/2015)|
|7.||Rickardson, Linda: 1 article (11/2009)|
|8.||Gullbo, Joachim: 1 article (11/2009)|
|9.||Bohlin, Lars: 1 article (11/2009)|
|10.||Lindskog, Magnus: 1 article (11/2009)|
|1.||Pulmonary Heart Disease (Cor Pulmonale)
11/01/1981 - "[Experimental study of the effect of convallatoxin on the main blood circulation parameters in chronic cor pulmonale]."
01/01/1982 - "[Use of strophanthin with corglycon in chronic cor pulmonale]."
02/01/1981 - "[Therapeutic effect of strophanthin and corglycon in chronic cor pulmonale]."
12/01/1963 - "[CONVALLATOXIN THERAPY OF COR PULMONALE IN CHRONIC EMPHYSEMA BRONCHITIS]."
|2.||Pathologic Constriction (Stenosis)
08/01/1998 - "[The effect of kavinton and korglycon on the central and cerebral hemodynamics of patients with an ischemic stroke in stenoses and occlusions of the major cerebral arteries]."
07/01/1991 - "Transient circulatory disorders of the brain arising in response to stenosis and occlusion of the major head arteries in 111 patients were treated with cardiotonic and vasoactive drugs (corglycon, strophanthin, sulfocamphocain, euphylline++, cavinton, finoptin). "
01/01/1991 - "Patients (n = 118) with initial manifestations of brain blood supply failure induced by stenoses and occlusions of the main vessels of the head were treated by cardio- and vasoactive drugs (corglycon, strophanthin, sulfocamphocaine, euphylline, cavinton, verapamil) under control of the systemic (by Evans blue dilution according to Stewart-Hamilton) and cerebral (by rheoencephalography and ultrasound dopplerography) hemodynamics. "
|4.||Myocardial Ischemia (Ischemic Heart Diseases)
01/01/1996 - "As many as 34 patients having stage II-III atherosclerotic dyscirculatory encephalopathy with coexisting ischemic heart disease in the presence of stenosing and occlusive lesions of major brain arteries were evaluated for effects pentoxiphyllin and corglycon on the clinical course of this medical condition as well as systemic and cerebral haemodynamics. "
12/01/1990 - "In 96 patients with coronary heart disease and stage II circulatory failure, the chronopharmacodynamics of strophanthin, corglycon, and nitrosorbide was studied by using acute clinical and pharmacological tests in the morning (8.00 a.m.), in the afternoon (2.00 p.m.), and in the evening (8.00 p.m.). "
|5.||Evans Blue (Blue, Evans)
|8.||Xanthinol Niacinate (Xavin)